Company / Revenue
Regenerative Medical Technology Group Inc. Revenue History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$5.1M
FY2025
5-year range
$437.9K / $5.1M
FY2021-FY2025
Trend
+24.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Revenue has increased for 6 consecutive years, from $30,103 in FY2019 to $5M in FY2025.
Based on SEC 10-K filings.
$5M in FY2025 with a 5-year CAGR of +147.4%.
Improved from $2M to $5M over the past 2 years.
Revenue over time
Growth rates
- 3-Year CAGR
- +49.4%
- 5-Year CAGR
- +147.4%
- 10-Year CAGR
- -
Key checks
Key Insights
- Regenerative Medical Technology Group Inc.'s revenue has grown for 6 consecutive years.
- 5-year CAGR of +147.4%, indicating consistent growth.
- In FY2025, revenue increased 24.2% year-over-year.
- Lowest revenue in the period was in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -19.75 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $5.1M | +24.2% |
| FY2024 | $4.1M | +70.4% |
| FY2023 | $2.4M | +57.5% |
| FY2022 | $1.5M | +249.5% |
| FY2021 | $437.9K | +695.0% |
| FY2020 | $55.1K | +83.0% |
| FY2019 | $30.1K | -39.9% |
| FY2018 | $50.1K | - |
As of FY2025 · SEC 10-K · Updated Jun 29, 2026